IL91154A - תהליך להסבת דאונורוביצין לדוקסורוביצין ע" י הודרוליזה חומצתיתשל דוקסורוביצין אוקסאלט המופק מ-41-ברומו-דאונורוביצין - Google Patents
תהליך להסבת דאונורוביצין לדוקסורוביצין ע" י הודרוליזה חומצתיתשל דוקסורוביצין אוקסאלט המופק מ-41-ברומו-דאונורוביציןInfo
- Publication number
- IL91154A IL91154A IL9115489A IL9115489A IL91154A IL 91154 A IL91154 A IL 91154A IL 9115489 A IL9115489 A IL 9115489A IL 9115489 A IL9115489 A IL 9115489A IL 91154 A IL91154 A IL 91154A
- Authority
- IL
- Israel
- Prior art keywords
- doxorubicin
- daunorubicin
- bromo
- hydrolysis
- oxalic acid
- Prior art date
Links
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 title claims abstract description 67
- 229960004679 doxorubicin Drugs 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 18
- -1 oxalate ester Chemical class 0.000 title claims abstract description 10
- KQRWYZDETCDVGB-TZSSRYMLSA-N (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromoacetyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CBr)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 KQRWYZDETCDVGB-TZSSRYMLSA-N 0.000 title claims description 17
- 229960000975 daunorubicin Drugs 0.000 title description 10
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 title description 7
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 title description 6
- 238000006243 chemical reaction Methods 0.000 title description 4
- 238000005903 acid hydrolysis reaction Methods 0.000 title description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 14
- 230000007062 hydrolysis Effects 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 53
- 235000006408 oxalic acid Nutrition 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- NAALWFYYHHJEFQ-ZASNTINBSA-N (2s,5r,6r)-6-[[(2r)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1h-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC(O)=CC=1)C(=O)C(C(N1)=O)=CC=C1C1=CC=C(S(=O)(=O)N(CCO)CCO)C=C1 NAALWFYYHHJEFQ-ZASNTINBSA-N 0.000 description 5
- 229960003109 daunorubicin hydrochloride Drugs 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 4
- 230000031709 bromination Effects 0.000 description 4
- 238000005893 bromination reaction Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 238000005907 ketalization reaction Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 241000187081 Streptomyces peucetius Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 238000006567 deketalization reaction Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 150000003901 oxalic acid esters Chemical class 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8822260A IT1230505B (it) | 1988-10-11 | 1988-10-11 | Procedimento per la conversione della daunorubicina in doxorubicina. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL91154A0 IL91154A0 (en) | 1990-03-19 |
| IL91154A true IL91154A (he) | 1994-01-25 |
Family
ID=11193796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9115489A IL91154A (he) | 1988-10-11 | 1989-07-28 | תהליך להסבת דאונורוביצין לדוקסורוביצין ע" י הודרוליזה חומצתיתשל דוקסורוביצין אוקסאלט המופק מ-41-ברומו-דאונורוביצין |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5008380A (he) |
| EP (1) | EP0363604A3 (he) |
| JP (1) | JPH02129197A (he) |
| KR (1) | KR900006357A (he) |
| AU (1) | AU615774B2 (he) |
| HU (1) | HUT52516A (he) |
| IL (1) | IL91154A (he) |
| IT (1) | IT1230505B (he) |
| ZA (1) | ZA895727B (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976830A (en) * | 1996-05-24 | 1999-11-02 | The Ohio State University Research Foundation | Methods of producing doxorubicin |
| FR2753703B1 (fr) * | 1996-09-20 | 1998-12-04 | Procede de synthese de l'acide mercapto-3-propionique | |
| DE69609845T2 (de) * | 1996-12-16 | 2000-12-21 | Pharmachemie B.V., Haarlem | Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin |
| RU2211842C1 (ru) * | 2002-01-31 | 2003-09-10 | Закрытое акционерное общество "Фармсинтез" | Способ получения доксорубицина гидрохлорида |
| JP2015507019A (ja) * | 2012-02-17 | 2015-03-05 | セルシオン コーポレイション | 感熱性ナノ粒子製剤およびその製造方法 |
| EP3279206B1 (en) * | 2015-03-30 | 2020-04-22 | Meiji Seika Pharma Co., Ltd. | Method for producing epirubicin and novel production intermediate therefor |
| CN108350015A (zh) * | 2015-11-05 | 2018-07-31 | 浙江海正药业股份有限公司 | 一种表柔比星或其盐酸盐的分离纯化方法 |
| WO2018048752A1 (en) | 2016-09-09 | 2018-03-15 | Irisys, Inc. | Lipsomal anticancer compositions |
| CN106749447B (zh) * | 2017-01-10 | 2018-02-13 | 鲁南制药集团股份有限公司 | 一种盐酸表柔比星中间体化合物 |
| CN108484689B (zh) * | 2018-03-06 | 2020-11-10 | 道中道（菏泽）制药有限公司 | 一种戊柔比星合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB691364A (en) * | 1949-02-18 | 1953-05-13 | Nat Starch Products Inc | Polysaccharide derivatives of substituted dicarboxylic acids |
| US3803124A (en) * | 1968-04-12 | 1974-04-09 | Farmaceutici It Soc | Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives |
| GB1566330A (en) * | 1977-02-16 | 1980-04-30 | Farmaceutici Italia | Anthracycline glycosides |
| JPS56156300A (en) * | 1980-04-26 | 1981-12-02 | Microbial Chem Res Found | Novel preparative method of anthracyclin derivative |
| GB8413464D0 (en) * | 1984-05-25 | 1984-07-04 | Erba Farmitalia | Anthracycline-anionic polymer conjugates |
| WO1986000073A1 (en) * | 1984-06-14 | 1986-01-03 | BIOGAL Gyógyszergyár | Process for preparing adriamycine and halide salts thereof |
| WO1990000173A1 (en) * | 1988-06-27 | 1990-01-11 | Board Of Regents, The University Of Texas System | 4'-deoxy-2'-halo-anthracycline antibiotics, methods for their use, and intermediates and methods for synthesis thereof |
-
1988
- 1988-10-11 IT IT8822260A patent/IT1230505B/it active
- 1988-11-09 US US07/269,199 patent/US5008380A/en not_active Expired - Lifetime
-
1989
- 1989-07-20 HU HU893682A patent/HUT52516A/hu unknown
- 1989-07-27 AU AU39011/89A patent/AU615774B2/en not_active Ceased
- 1989-07-27 ZA ZA895727A patent/ZA895727B/xx unknown
- 1989-07-28 IL IL9115489A patent/IL91154A/he not_active IP Right Cessation
- 1989-08-07 JP JP1204524A patent/JPH02129197A/ja active Pending
- 1989-08-13 EP EP89114981A patent/EP0363604A3/en not_active Ceased
- 1989-08-30 KR KR1019890012408A patent/KR900006357A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02129197A (ja) | 1990-05-17 |
| EP0363604A3 (en) | 1990-07-25 |
| US5008380A (en) | 1991-04-16 |
| IL91154A0 (en) | 1990-03-19 |
| IT1230505B (it) | 1991-10-25 |
| KR900006357A (ko) | 1990-05-08 |
| EP0363604A2 (en) | 1990-04-18 |
| AU3901189A (en) | 1990-04-26 |
| AU615774B2 (en) | 1991-10-10 |
| ZA895727B (en) | 1990-04-25 |
| HUT52516A (en) | 1990-07-28 |
| IT8822260A0 (it) | 1988-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1470197A3 (ru) | Способ очистки сырого доксорубицина | |
| US4289703A (en) | Antibiotics | |
| EP0342990B1 (en) | Process for preparing erythromycin A oxime or a salt therof | |
| US4757138A (en) | Process for producing etoposide | |
| CZ54495A3 (en) | Process for preparing and/or purification of clavulanic acid | |
| US5008380A (en) | Process for the conversion of daunorubicin into doxorubicin | |
| US4071536A (en) | Antibiotics | |
| COXON et al. | Simplified preparation of sophorose (2-O-β-D-glucopyranosyl-D-glucose) | |
| JPH06197782A (ja) | 粗クラブラン酸の精製方法 | |
| US3977943A (en) | Antibiotics | |
| US4387232A (en) | Process for preparing N-acylcarnosine | |
| US4061676A (en) | Recovery of doxycycline and products thereof | |
| Shimizu et al. | Synthetic studies on leupeptins and their analogs | |
| EP0094632B1 (en) | (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same | |
| EP0517345B1 (en) | Intermediates of the mureidomycin group, their preparation, and their use | |
| US3860607A (en) | Process for preparing hydroxy-l-proline or n-acetyl-hydroxy-l-proline from hydrolyzed gelatin | |
| US4495348A (en) | Derivative of cephamycin C | |
| US5338418A (en) | Process for production of hydroxocobalamin | |
| US3226305A (en) | Biological transformation of 1,3,10,11,12-pentahydroxynaphthacene - 2 - carboxamides to tetracycline antibiotics | |
| HK1005736B (en) | Intermediates of the mureidomycin group, their preparation, and their use | |
| US4290972A (en) | Process for the production of 4-aminobutyric acid or its derivatives | |
| US4204058A (en) | Process for obtaining cephalosporin C and the salts and derivatives thereof from culture filtrates or culture solutions | |
| KR100274787B1 (ko) | 독소루비신및이의염산염의제조정제방법 | |
| EP0251327B1 (en) | Process for production of anthracycline compound r2ox2 | |
| JP2512050B2 (ja) | 新規抗かび性抗生物質デキシロシルベナノマイシンｂならびにその製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |